• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enochian Biosciences, Inc. - Common Stock (NQ:ENOB)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.7000 (2)
Ask (Size) 0.7350 (1)
Prev. Close 0.7000
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 24,187,356
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
November 22, 2023
Via Investor Brand Network
Topics Artificial Intelligence

Performance

More News

Read More
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
October 20, 2023
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
October 02, 2023
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
September 29, 2023
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
August 30, 2023
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
August 23, 2023
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders
August 18, 2023
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies
August 17, 2023
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies
August 16, 2023
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform
August 15, 2023
Via Investor Brand Network
Topics Intellectual Property
Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
August 09, 2023
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
August 09, 2023
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
July 31, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
July 19, 2023
Via Benzinga
News headline image
3 Doomed Biotech Stocks Destined for Disaster ↗
July 17, 2023
Via InvestorPlace
News headline image
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
July 12, 2023
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
July 12, 2023
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
July 11, 2023
Via Benzinga
News headline image
Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
July 03, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
July 03, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 30, 2023
Via Benzinga
News headline image
Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
June 23, 2023
From Enochian BioSciences, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
June 13, 2023
Via Benzinga
News headline image
Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review
June 08, 2023
From Enochian BioSciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Enochian Biosciences, Inc. - Common Stock publicly traded?
Yes, Enochian Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enochian Biosciences, Inc. - Common Stock trade on?
Enochian Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enochian Biosciences, Inc. - Common Stock?
The ticker symbol for Enochian Biosciences, Inc. - Common Stock is ENOB on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap